Wird geladen...
Potential Therapeutic Targets in Uterine Sarcomas
Uterine sarcomas are rare tumors accounting for 3,4% of all uterine cancers. Even after radical hysterectomy, most patients relapse or present with distant metastases. The very limited clinical benefit of adjuvant cytotoxic treatments is reflected by high mortality rates, emphasizing the need for ne...
Gespeichert in:
| Veröffentlicht in: | Sarcoma |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi Publishing Corporation
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4632006/ https://ncbi.nlm.nih.gov/pubmed/26576131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/243298 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|